Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael W Graner

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Seminars in Immunopathology|June 6, 2018
Tumor-derived exosomes, microRNAs, and cancer immune suppressionMichael W Graner, Sathya Schnell, Michael R Olin
Frontiers in Oncology|January 23, 2015
Endoplasmic reticulum chaperones and their roles in the immunogenicity of cancer vaccinesMichael W Graner, Kevin O Lillehei, Emmanuel Katsanis
Journal of Clinical Medicine|May 27, 2023
Immunopathology of Extracellular Vesicles in Macrophage and Glioma Cross-TalkTimothy J Kopper, Xiaoli Yu, Michael W Graner
Blood|October 24, 2002
Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cellsHanping Feng, Yi Zeng, Michael W Graner, et al.
Cancer Immunology, Immunotherapy : CII|April 2, 2003
Tumor-derived chaperone-rich cell lysates are effective therapeutic vaccines against a variety of cancersMichael W Graner, Yi Zeng, Hanping Feng, et al.
Blood|February 11, 2003
Tumor-derived, chaperone-rich cell lysate activates dendritic cells and elicits potent antitumor immunityYi Zeng, Hanping Feng, Michael W Graner, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 19, 2007
The heat shock response and chaperones/heat shock proteins in brain tumors: surface expression, release, and possible immune consequencesMichael W Graner, R Ian Cumming, Darell D Bigner
Future Oncology (London, England)|June 4, 2008
Combating immunosuppression in gliomaEleanor A Vega, Michael W Graner, John H Sampson
Pharmacogenomics and Personalized Medicine|March 18, 2014
Glioblastoma extracellular vesicles: reservoirs of potential biomarkersJasmina S Redzic, Timothy H Ung, Michael W Graner
Blood|September 18, 2004
Induction of BCR-ABL-specific immunity following vaccination with chaperone-rich cell lysates derived from BCR-ABL+ tumor cellsYi Zeng, Michael W Graner, Sylvia Thompson, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Seminars in Immunopathology|June 6, 2018
Tumor-derived exosomes, microRNAs, and cancer immune suppressionMichael W Graner, Sathya Schnell, Michael R Olin
Frontiers in Oncology|January 23, 2015
Endoplasmic reticulum chaperones and their roles in the immunogenicity of cancer vaccinesMichael W Graner, Kevin O Lillehei, Emmanuel Katsanis
Journal of Clinical Medicine|May 27, 2023
Immunopathology of Extracellular Vesicles in Macrophage and Glioma Cross-TalkTimothy J Kopper, Xiaoli Yu, Michael W Graner
Blood|October 24, 2002
Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cellsHanping Feng, Yi Zeng, Michael W Graner, et al.
Cancer Immunology, Immunotherapy : CII|April 2, 2003
Tumor-derived chaperone-rich cell lysates are effective therapeutic vaccines against a variety of cancersMichael W Graner, Yi Zeng, Hanping Feng, et al.
Blood|February 11, 2003
Tumor-derived, chaperone-rich cell lysate activates dendritic cells and elicits potent antitumor immunityYi Zeng, Hanping Feng, Michael W Graner, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 19, 2007
The heat shock response and chaperones/heat shock proteins in brain tumors: surface expression, release, and possible immune consequencesMichael W Graner, R Ian Cumming, Darell D Bigner
Future Oncology (London, England)|June 4, 2008
Combating immunosuppression in gliomaEleanor A Vega, Michael W Graner, John H Sampson
Pharmacogenomics and Personalized Medicine|March 18, 2014
Glioblastoma extracellular vesicles: reservoirs of potential biomarkersJasmina S Redzic, Timothy H Ung, Michael W Graner
Blood|September 18, 2004
Induction of BCR-ABL-specific immunity following vaccination with chaperone-rich cell lysates derived from BCR-ABL+ tumor cellsYi Zeng, Michael W Graner, Sylvia Thompson, et al.
Pageof 8